本文選題：藥品價格談判 + 價格協(xié)議�。� 參考：《衛(wèi)生經(jīng)濟研究》2017年05期

【摘要】：根據(jù)國際主流分類標準,將英國創(chuàng)新藥品價格協(xié)議分為療效導(dǎo)向和經(jīng)濟導(dǎo)向兩種類型。對重點協(xié)議進行個案研究的基礎(chǔ)上進行綜合分析,研究各協(xié)議的設(shè)計因素與實施機制,進一步探求英國創(chuàng)新藥品價格談判協(xié)議在具體實踐中的制度效益與制度效率,為我國藥品價格談判的設(shè)計提供借鑒。
[Abstract]:According to the international mainstream classification standard, the UK innovative drug price agreement is divided into two types: curative effect-oriented and economic-oriented. On the basis of case study of key agreements, this paper makes a comprehensive analysis, studies the design factors and implementation mechanism of each agreement, and further explores the institutional benefits and efficiency of the innovative drug price negotiation agreement in the UK in practice. It provides reference for the design of drug price negotiation in China.
【作者單位】： 中國藥科大學(xué)國際醫(yī)藥商學(xué)院;
【分類號】：R95
，

本文編號：2076585